| |
SRI International
Digest #14
Subscribe
to the SRI International Digest, a quarterly e-newsletter, or view
our previous issues.
Journalists: Sign
up for a version of the Digest tailored to your needs.
SRI International, an independent
research institute, is helping meet important R&D challenges for our clients.
In this quarterly edition of the Digest, learn about a DARPA-funded program
that could save lives on the battlefield. Also read about
our work to fight bioterrorism and breast
cancer, and how we help clients build better products through microsystems
innovations.
IN THIS ISSUE:
Trauma
Pod Could Save Lives on the Battlefield
Imagine an automated medical treatment system that does not require
onsite medical personnel on the front lines of battle that is ready
to receive, assess, and stabilize wounded soldiers during the first
critical hours following injury. The Defense Advanced Research Projects
Agency (DARPA) has taken a significant step toward that goal by
awarding a multi-organization team a $12 million, two-year contract
to develop such a system. SRI, a pioneer in robotic surgery is the
lead systems integrator for the program.
The groundbreaking
program is an important step toward ensuring a future generation
of battlefield-based unmanned medical treatment systems. These “trauma
pods” could stabilize injured soldiers within minutes after
a battlefield trauma and administer life-saving medical and surgical
care prior to evacuation and during transport.
Read the Associated
Press and San
Francisco Chronicle articles for additional information.
Fighting Bioterrorism: SRI Part of
$15 Million NIH Contract
With a goal of protecting U.S. citizens against the harmful effects
of biological agents used in terrorism, biopharmaceutical company
XOMA, Ltd. was recently awarded
a $15 million, 18-month contract from the National Institute of
Allergy and Infectious Diseases (NIAID). XOMA, which will produce
three botulinum neurotoxin monoclonal antibodies, has selected SRI
to develop the necessary potency assays to support antibody characterization.
Read more information
from XOMA.
Breast Cancer Research: SRI
Models Cellular Networks
Under a new grant from the National Cancer Institute and the Lawrence
Berkeley National Laboratory for the study of biological networks
associated with cancer cell lines, SRI
will develop a model of cellular signaling networks related
to human breast cancer. SRI will apply Pathway Logic software, its
novel approach to modeling biological entities and processes. The
San
Jose Mercury News covered the news.
Metabolic Pathways of "Rabbit
Fever" Identified
Using a groundbreaking computational approach, SRI and collaborators
have identified
the predicted metabolic pathways of the bacterium that causes
tularemia, or “rabbit fever” in animals and humans.
An article about the findings is published in the February 2005
issue of Nature Genetics.
In related breakthrough, SRI researchers have performed a computational
analysis of the human genome to predict metabolic pathways and new
gene functions. Using SRI’s HumanCyc
genome database, the analysis assigned 622 enzymes to roles in 135
predicted pathways. Scientists can use HumanCyc as a “power
tool” to understand the genome in useful ways. Results are
available on the HumanCyc website. An article about the findings
was published in the December 22, 2004 edition of Genome
Biology.
Industry Leader Walter Moos Joins SRI
as VP of Biosciences
Walter H.
Moos, Ph.D., has joined
SRI as Vice President of the Biosciences Division. In this role,
Dr. Moos will direct the institute's pharmaceutical and biotechnology
discovery and development teams, which provide contract R&D
services to government and commercial clients. Dr. Moos has more
than 20 years of experience, and most recently served as chairman
and CEO of MitoKor, Inc. Previously, he was a corporate VP at Chiron
Corporation.
Computer Mouse Inventor Doug Engelbart
Joins Hall of Fame
Douglas Engelbart, Ph.D., inventor
of the computer mouse and other computing firsts while at SRI,
has been named
to the Silicon Valley Engineering Council Hall of Fame.
No Project Too Small for the MicroSystems
Innovation Center
Under direction of Dr. Joseph Stetter, SRI's MicroSystems
Innovation Center develops micro- and nanometer-scale structures,
devices, and systems. The Center's design teams focus on real-world
needs, including sensors for automotive and environmental applications;
microdispensing and sample collection systems for biomedical and
chemical environments; flat-panel displays and printers for consumer
electronics; satellite ion thrusters for space technology; and microwave
tubes and electronic optics. A new state-of-the-art facility on
SRI's Menlo Park, CA campus houses the Center.
Meet SRI People
Meet Phil
Harman, SRI's director of Congressional relations; Grace
Chou, business development director; and Dan
Humphrey, associate director of our Center
for Education Policy.
SRI in the News
Military.com
describes SRI’s role in the Phraselator, a handheld speech-based
translation device used by soldiers for real-time language translation
in overseas operations.
The San
Francisco Chronicle includes SRI in a round-up of “research
powerhouses” in the Bay Area.
Read more
SRI news.
Upcoming Events
Cyber security: The Department of Homeland Security Cyber
Security Research and Development Center will hold an invitation-only
Emerging Security Technology Forum at SRI’s Arlington, Virginia
office on April 13-14. Invited nformation security companies will
present innovative technologies to defend against Distributed Denial
of Service (DDoS) and worm attacks. Attendees will include government
technologists, technical managers, and others responsible for purchasing
new security technologies for cyber infrastructure. SRI manages
the Center for the DHS.
Biosciences: Learn about SRI's end-to-end drug
discovery and drug development services at these upcoming events:
* American Association for Cancer Research annual meeting, Anaheim,
CA, April 16-20
* BIO 2005, Philadelphia, June 19-22
CONTACT US
For more information on SRI's innovations and how we can help you,
contact bizdev@sri.com. The SRI Digest welcomes your feedback. Please
send suggestions or comments to newsletter@sri.com. Start or discontinue
a subscription by sending an email to newsletter@sri.com.
|
|
R&D Divisions